Femcon and anaemia Patient Reports February 11, 2012



Femcon Side Effects Report #5479073-3
Femcon side effect was reported by a Physician from UNITED STATES on Sept 17, 2007. Female patient, 18 years of age, was diagnosed with haemorrhage, vaginal haemorrhage and was treated with Femcon. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, hyperhidrosis, pain in extremity, vision blurred. Femcon dosage: 0.4MG/35MCG, QD, ORAL THREE TO FOUR TIMES DAILY, ORAL. During the same period patient was treated with FEMCON FE, FEMCON FE, FEMCON FE, ZOLOFT, HALDOL, PAXIL, CODEINE SUL. Patient recovered.

Femcon Side Effects Report #5533314-2
Femcon side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2007. Female patient, 18 years of age, was diagnosed with haemorrhage and was treated with Femcon. After drug was administered, patient experienced the following side effects: anaemia, blood iron decreased, dyspnoea, hyperhidrosis, pain in extremity, vision blurred. Femcon dosage: 0.4MG/35MCG, QD, ORAL, THREE TO FOUR TIME DAILY, ORAL. During the same period patient was treated with FEMCON FE, ZOLOFT, HALDOL, PAXIL, IRON, CODEINE SUL. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Femcon